Quick Answer
HAEMONETICS CORP reported Gross Profit of $748.96 million for fiscal year 2025.
HAEMONETICS CORP Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $748.96M | +8.3% |
| 2024 | $691.55M | +12.4% |
| 2023 | $615.10M | +21.7% |
| 2022 | $505.50M | +27.1% |
| 2021 | $397.84M | -17.9% |
| 2020 | $484.51M | +16.0% |
| 2019 | $417.54M | +1.4% |
| 2018 | $411.91M | +8.8% |
| 2017 | $378.49M | -6.8% |
| 2016 | $405.91M | -6.6% |
| 2015 | $434.42M | -7.2% |
| 2014 | $468.37M | +9.4% |
| 2013 | $428.13M | +15.9% |
| 2012 | $369.24M | +4.0% |
| 2011 | $355.21M | +5.3% |
| 2010 | $337.48M | +9.5% |
| 2009 | $308.17M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $202.39M | +4.6% | +3.9% |
| September 30, 2025 | $194.74M | +3.9% | +1.3% |
| June 30, 2025 | $192.24M | +9.9% | -0.7% |
| December 31, 2024 | $193.55M | +8.8% | +3.3% |
| September 30, 2024 | $187.44M | +9.9% | +7.2% |
| June 30, 2024 | $174.92M | +4.6% | -1.7% |
| December 31, 2023 | $177.87M | +12.1% | +4.3% |
| September 30, 2023 | $170.51M | +8.0% | +1.9% |
- HAEMONETICS CORP showed an increase of +8.3% in Gross Profit compared to the prior fiscal year.
- Over the 2009–2025 period, HAEMONETICS CORP’s gross profit has grown by 143.0% (from $308.17 million to $748.96 million).
- The most recent figure is from HAEMONETICS CORP’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 21, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: